Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/09/1994 | EP0383751B1 Production of human parathyroid hormone from microorganisms |
03/09/1994 | CN1083527A Recombinant entomopoxvirus |
03/09/1994 | CN1083524A Deletion mutants as vaccines for cholera |
03/09/1994 | CN1083389A A novel anti-neoplastic cytokine |
03/08/1994 | US5292802 Collagen-polymer tubes for use in vascular surgery |
03/08/1994 | US5292667 Detection and treatment of ulcerative colitis |
03/08/1994 | US5292662 Position-specific insertion vectors and method of using same |
03/08/1994 | US5292656 Rat osteosarcoma cell line OSR-6 |
03/08/1994 | US5292654 Mutant EPO receptor and uses therefor |
03/08/1994 | US5292653 Equine herpesvirus 1 tk mutants |
03/08/1994 | US5292646 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
03/08/1994 | US5292643 Fusaric acid resistant genes |
03/08/1994 | US5292642 Methods and compositions for the detection of monocyte cytotoxicity inducing factor |
03/08/1994 | US5292510 WS7622A mono- or di- sulfate, process for preparation thereof and use thereof |
03/08/1994 | CA2105594A1 Transgenic non-human mammals with an oncogene under the control of an inducible liver-specific promoter |
03/08/1994 | CA1327676C Isolation of an immunoglobulin rich fraction from whey |
03/08/1994 | CA1327675C Process for the purification of placental tissue protein pp4 |
03/08/1994 | CA1327674C Method and apparatus for separating proteins |
03/08/1994 | CA1327566C Brain-specific drug delivery |
03/05/1994 | CA2105425A1 Process for the production of protease inhibitors |
03/05/1994 | CA2105213A1 Test for lupus anticoagulant |
03/04/1994 | CA2470670A1 Tnf ligands |
03/03/1994 | WO1994005008A1 Compositions of bacteriorhodopsin variants with increased memory time and their use |
03/03/1994 | WO1994004927A1 Method for diagnosing and monitoring sepsis |
03/03/1994 | WO1994004698A1 Novel protein and gene coding for the same |
03/03/1994 | WO1994004697A1 Novel elafin derivative |
03/03/1994 | WO1994004696A1 Translocation signal facilitated nuclear delivery of macromolecules |
03/03/1994 | WO1994004693A2 Novel plants and processes for obtaining them |
03/03/1994 | WO1994004690A1 Bispecific immunoadhesins |
03/03/1994 | WO1994004689A1 Recombinant toxin with increased half-life |
03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
03/03/1994 | WO1994004685A1 Recombinant antigens and vaccines of bovine ephemeral fever virus |
03/03/1994 | WO1994004684A1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
03/03/1994 | WO1994004683A1 Bordetella bronchiseptica vaccine |
03/03/1994 | WO1994004682A1 Bacteriocin |
03/03/1994 | WO1994004681A1 Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof |
03/03/1994 | WO1994004680A1 Human interleukin-13 |
03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
03/03/1994 | WO1994004677A1 The use of cd4 plasma membrane vesicles (pmv) as a therapeutic agent for aids |
03/03/1994 | WO1994004676A1 Stress protein epitopes |
03/03/1994 | WO1994004675A2 Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family |
03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
03/03/1994 | WO1994004673A1 Fungal promoters active in the presence of glucose |
03/03/1994 | WO1994004672A1 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals |
03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |
03/03/1994 | WO1994004670A1 Use of the cytokine ip-10 as an anti-tumor agent |
03/03/1994 | WO1994004669A1 Mice having cftr defect as model for cystic fibrosis |
03/03/1994 | WO1994004668A1 Regulation of the sinusal rhythm by a human membrane receptor sequence |
03/03/1994 | WO1994004661A1 Virus obtainable from human neuroblastoma cells |
03/03/1994 | WO1994004660A1 Insect viruses and their uses in protecting plants |
03/03/1994 | WO1994004659A1 A novel b-lymphoma cell line and antigen |
03/03/1994 | WO1994004651A1 Liquid detergents containing a peptide aldehyde |
03/03/1994 | WO1994004573A1 cDNA CLONE ENCODING AN EXPRESSIBLE GABA TRANSPORTER |
03/03/1994 | WO1994004572A1 Allergenic peptide |
03/03/1994 | WO1994004571A1 A substrate for the epidermal growth factor receptor kinase |
03/03/1994 | WO1994004570A1 Cd40 ligand, anti cd40 antibodies, and soluble cd40 |
03/03/1994 | WO1994004569A1 Use of specific binding molecules in potentiating igf-i activity |
03/03/1994 | WO1994004567A1 A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
03/03/1994 | WO1994004566A1 Lipopolysaccharide-binding protein and process for producing the same |
03/03/1994 | WO1994004565A2 Ipnv vaccine |
03/03/1994 | WO1994004564A1 T cell epitopes of ryegrass pollen allergen |
03/03/1994 | WO1994004563A1 PEPTIDES CONTAINING RESPECTIVE AMINO ACID SEQUENCES SELECTED FROM AMONG THOSE OF LIPOPROTEIN(a) AND APOLIPOPROTEIN(a), ANTIBODIES RESPECTIVELY RECOGNIZING THESE AMINO ACID SEQUENCES, AND METHOD OF ASSAYING WITH THESE ANTIBODIES |
03/03/1994 | WO1994004562A1 Mammalian gap-43 compositions and methods of use |
03/03/1994 | WO1994004561A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
03/03/1994 | WO1994004560A1 Schwann cell mitogenic factor, its preparation and use |
03/03/1994 | WO1994004559A1 Method of recovering endothelial membrane from tissue and applications thereof |
03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
03/03/1994 | WO1994004552A1 Opioid receptor genes |
03/03/1994 | WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism |
03/03/1994 | WO1994004196A1 Tumour therapy |
03/03/1994 | WO1994004190A1 Regulation of cellular invasiveness |
03/03/1994 | WO1994004182A1 Method of treating asthma |
03/03/1994 | WO1994004181A1 Heparin neutralization with multimeric peptides |
03/03/1994 | WO1994004179A1 Method for inhibiting hiv replication using il-4 |
03/03/1994 | WO1994004178A1 Method of inhibiting cell proliferation using apolipoprotein e |
03/03/1994 | WO1994004177A1 Methods useful in endotoxin prophylaxis and therapy |
03/03/1994 | WO1994004176A1 Novel peptides for heparin anticoagulation reversal |
03/03/1994 | WO1994004174A1 Cytokine applications |
03/03/1994 | WO1994004171A1 Immunomodulatory peptides |
03/03/1994 | WO1994004170A1 Method of treating epstein-barr virus infection |
03/03/1994 | WO1994004121A1 Bystander suppression of retroviral-associated neurological disease |
03/03/1994 | WO1994004033A1 Anti-microbial composition |
03/03/1994 | WO1994004032A1 Composition and method for altering dna sequences by homologous recombination |
03/03/1994 | WO1994004030A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
03/03/1994 | WO1994001451A3 Method for modification of recombinant polypeptides |
03/03/1994 | WO1993023550A3 Activation of oligomerizing receptors by using fused receptor ligands |
03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
03/03/1994 | WO1993010747A3 Technetium-99m labeled peptides for imaging |
03/03/1994 | DE4228787A1 Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate New HIV-1 isolates of subtype vaccine against HIV-1 virus infection of this subtype and methods for their production, use of the HIV-1 virus isolates |
03/03/1994 | CA2224048A1 Test kit for testing microbiologically-contaminated material |
03/03/1994 | CA2143453A1 Regulation of cellular invasiveness |
03/03/1994 | CA2143326A1 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals |
03/03/1994 | CA2143316A1 Novel plants and processes for obtaining them |
03/03/1994 | CA2143308A1 Translocation signal facilitated nuclear delivery of macromolecules |
03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
03/03/1994 | CA2142990A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
03/03/1994 | CA2142989A1 A novel b-lymphoma cell line and antigen |
03/03/1994 | CA2142902A1 Virus obtainable from human neuroblastoma cells |
03/03/1994 | CA2142860A1 Human interleukin-13 |